Abstract
A new series of 5-alkylthio-4-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one derivatives (4a-w) have been synthesized and tested for their anticonvulsant activity using the maximal electroshock (MES) test. The results indicated that all of the target compounds exhibited anticonvulsant activity in the MES test. Of the compounds tested, compound 4g showed the most potent level of activity with an ED50 value of 38.7 mg/kg, a TD50 value of 633.7 mg/kg, and a superior protective index (PI) value of 16.4, revealing the greater margin of safety of compound 4g versus the standard drug carbamazepine (PI = 6.5). In addition, the potency of compound 4g against seizures induced by pentylenetetrazole in the chemical-induced seizure test was also established.
Keywords: Synthesis, Triazolone, Anticonvulsant activity, Maximal electroshock, Pentylenetetrazole, Neurotoxicity, Rotarod test.
Letters in Drug Design & Discovery
Title:Synthesis and Evaluation of the Anticonvulsant Activity of 5-alkylthio-4- phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one Derivatives
Volume: 10 Issue: 6
Author(s): Yan Zheng, Xian-Qing Deng, Bing Shu, Shi-Ben Wang, Xu Cao and Zhe-Shan Quan
Affiliation:
Keywords: Synthesis, Triazolone, Anticonvulsant activity, Maximal electroshock, Pentylenetetrazole, Neurotoxicity, Rotarod test.
Abstract: A new series of 5-alkylthio-4-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one derivatives (4a-w) have been synthesized and tested for their anticonvulsant activity using the maximal electroshock (MES) test. The results indicated that all of the target compounds exhibited anticonvulsant activity in the MES test. Of the compounds tested, compound 4g showed the most potent level of activity with an ED50 value of 38.7 mg/kg, a TD50 value of 633.7 mg/kg, and a superior protective index (PI) value of 16.4, revealing the greater margin of safety of compound 4g versus the standard drug carbamazepine (PI = 6.5). In addition, the potency of compound 4g against seizures induced by pentylenetetrazole in the chemical-induced seizure test was also established.
Export Options
About this article
Cite this article as:
Zheng Yan, Deng Xian-Qing, Shu Bing, Wang Shi-Ben, Cao Xu and Quan Zhe-Shan, Synthesis and Evaluation of the Anticonvulsant Activity of 5-alkylthio-4- phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one Derivatives, Letters in Drug Design & Discovery 2013; 10 (6) . https://dx.doi.org/10.2174/1570180811310060011
DOI https://dx.doi.org/10.2174/1570180811310060011 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Postpartum Psychiatric Disorders: What Do We Know And Where Do We Go?
Current Psychiatry Reviews Neuropharmacology of Vestibular System Disorders
Current Neuropharmacology Relationship Between Oxidative Stress, Tau Level and Antioxidant Mechanisms of the KEAP-1/NRF-2/HO-1 in Children with Hydrocephalus
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Medical and Dental Implications of Down Syndrome: A Review Part 1: General and Craniofacial Characteristic
Applied Clinical Research, Clinical Trials and Regulatory Affairs The Emerging Role of Coenzyme Q-10 in Aging, Neurodegeneration, Cardiovascular Disease, Cancer and Diabetes Mellitus
Current Neurovascular Research Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases
Protein & Peptide Letters <i>Nigella sativa</i> – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
The Natural Products Journal A Novel Efficient Machine Learning Approach for Multiclass Classification of EEG Signal
Recent Patents on Computer Science PDZ Domain-mediated Protein Interactions: Therapeutic Targets in Neurological Disorders
Current Medicinal Chemistry Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde?
Current Neuropharmacology Gene Therapy for Ischemic Brain Diseases
Current Gene Therapy Patient’s Perceptions of the Cannabis-psychosis Link - A Systematic Review
Current Pharmaceutical Design Preserving Brain Function During Development and Aging with Erythropoietin
Current Neurovascular Research Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects
Current Radiopharmaceuticals Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders
Central Nervous System Agents in Medicinal Chemistry Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy
Current Drug Targets Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Recent Patents on CNS Drug Discovery (Discontinued) Therapeutic Drugs that Slow the Heart Rate of Early Rat Embryos. Is there a Risk for the Human?
Current Pharmaceutical Design Editorial
Drug Delivery Letters